Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Analytikerkommentar

Scanfil Q3'25 earnings preview: Turn to earnings growth  

Af Antti ViljakainenHead of Research
Scanfil
Estimates Q3'24Q3'25Q3'25eQ3'25eConsensus2025e
MEUR / EUR ComparisonActualizedInderesConsensusLow HighInderes
Revenue 173 197    841
EBITA (adj.) 12.8 14.6    60.5
EBIT 12.4 13.5    56.4
PTP 12.2 13.1    54.3
EPS (reported) 0.14 0.16    0.65
          
Revenue growth-% -18.6 % 13.7 %    7.8 %
EBITA-% (adj.) 7.4 % 7.4 %    7.2 %

Source: Inderes

Translation: Original published in Finnish on 10/20/2025 at 8:32 am EET.

Scanfil will publish its Q3 report on Friday at around 8:00 am EET. In our view, Scanfil has progressed in Q3 with the ramp-up of projects won last year, in addition to which the SRX acquisition has supported the figures inorganically in Q3. Thus, we expect Scanfil's operating profit to have finally turned to growth in Q3. However, we have marginally lowered our forecasts, as Scanfil did not close the ADCO acquisition in Q3 as originally scheduled (though we expect the acquisition to close in Q4). We estimate Scanfil will reiterate its guidance, although there may be slight downward pressure on the upper ends of the rather wide ranges, given the continued subdued macroeconomic picture in Europe.

Revenue should turn to organic growth

We estimate that the underlying tone of Scanfil's demand has been roughly similar to the satisfactory comparison period, as a clear pick-up in industrial activity has still been limited. However, we expect projects won last year to have supported the company's revenue, as deliveries should already accelerate after the H1 ramp-up phase. In addition, the SRX acquisition, completed last October, has supported inorganic growth by approximately 4–5 percentage points in Q3. Thus, we expect Scanfil's revenue to have grown by 14% in Q3 to 197 MEUR.

We expect revenue development to have turned slightly positive in Central and Northern Europe due to project wins, while reported growth in APAC is strong due to the acquisition. In the Americas, US trade policy may still have had positive short-term demand effects, although in the longer term and considering indirect effects, global trade restrictions are, in our opinion, also a bad thing for Scanfil.

We also expect the company to deliver earnings improvement driven by revenue growth

We estimate Scanfil's adjusted EBIT for Q3 to be 14.6 MEUR, 14% higher than in the comparison period. In our forecast, earnings growth is driven by organic revenue growth and the SRX acquisition. Of the regions, we expect the Americas, APAC, and Central Europe to have moderately improved their results, while in Northern Europe, the result to be flat year-on-year. We estimate profitability to have remained stable at Scanfil's baseline adjusted EBITA margin of just over 7% in Q3.

On the lower lines, our financial expense and tax forecasts are in line with Scanfil's normalized levels, although non-cash FX differences that are not material to the company as a whole could slightly impact financing costs and EPS. We expect Scanfil's EPS to have risen quite clearly from the comparison period, driven by the operating result. From a cash flow perspective, the report may be slightly weaker than the result, as the turnaround in revenue may have increased working capital, although the company still has room for improvement in working capital turnover.

Reiterating the guidance is the base scenario

Scanfil has issued guidance for the current year, according to which the company's 2025 revenue will be 780–920 MEUR and adjusted EBITA 55–68 MEUR. We expect the company to reiterate its guidance at this point in the year, as projects won last year and the SRX acquisition, which provided inorganic growth until Q3, as well as the ADCO and MB acquisitions, which are still expected to be completed in Q4, will act as buffers, even if the recovery in demand may still be limited. In our view, the upper ends of the guidance range are starting to look optimistic given the current situation, so a slight decrease in the upper ends or a moderate reduction in the mid-points of the ranges would not be a huge surprise.

Scanfil is an international electronics contract manufacturer, specializing in industrial and B2B customers. Services include manufacturing of end products and components such as PCBs. Manufacturing services are the core of the company, supported by design, supply chain and modernization services. The company operates globally in Europe, America and Asia. Customers are primarily found in the process automation, energy efficiency, green efficiency and medical segments.

Læs mere på virksomhedsside

Key Estimate Figures17.07

202425e26e
Omsætning779,9844,01.005,7
vækst-%-13,5 %8,2 %19,2 %
EBIT (adj.)54,960,975,7
EBIT-% (adj.)7,0 %7,2 %7,5 %
EPS (adj.)0,620,700,85
Udbytte0,240,260,28
Udbytte %2,9 %2,7 %2,9 %
P/E (adj.)13,314,111,6
EV/EBITDA7,69,17,1

Forumopdateringer

Kommentaren er her. Afslutningen af MB-handlen trækker lidt ud, hvilket opklaringen af den uventede komplikation forårsaget af branden sandsynligvis...
20.11.2025, 08.37
af Antti Viljakainen
5
Lad os lægge denne friske Scanfil-meddelelse her. 19.11.2025 12:15:11 EET | Scanfil Oyj | Insiderviden Scanfil Oyj Børsmeddelelse 19.11.2025...
19.11.2025, 23.02
af Sijoittaja-alokas
3
Isa og Antti diskuterede Scanfil. Det overordnede billede af Scanfils Q3-rapport var ret neutralt. Udsigterne er positive på både kort og lang...
18.11.2025, 23.22
af Sijoittaja-alokas
1
Inderes Scanfil: Revenue growth could be close to 20% y/y in 2026 - Nordea - Inderes Organic growth returned in Q3 y/y after some challenging...
27.10.2025, 09.19
af Dissidentti
4
Antti har lavet en ny virksomhedsrapport efter Q3. *Scanfils Q3-rapport, der blev offentliggjort fredag, var efter vores mening ret neutral,...
27.10.2025, 07.12
af Sijoittaja-alokas
3
Vækst i Amerika Omsætningen voksede især i Amerika på trods af valutakurseffekter. ”Justeret for effekten af valutakursændringer voksede oms...
24.10.2025, 06.00
af Dissidentti
7
Scanfil Q3 2025: Tilbage til organisk vækst! Omsætningen voksede 10,4 % til 191,3 mio. euro, og EBITA voksede til 14,1 mio. euro Den organiske...
24.10.2025, 05.11
af Pasi Hiedanpää
23
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.